期刊文献+

HBsAg和HBsAb双阳性乙肝患者血清中HBsAb确认方法的建立 被引量:6

Establishment of confirmatory test for HBsAb in serum of coexistence of hepatitis B surface antigen and antibodies to HBsAg
原文传递
导出
摘要 目的 建立一种基于酶联免疫吸附实验( ELISA)的HBsAb确认方法,验证HBsAg和HBsAb双阳性的乙肝患者血清中HBsAb阳性的真实性,剔除假阳性结果,避免错误诊断.方法收集60例电化学发光免疫分析法( ECLIA)检测的HBsAg浓度在1000 COI以上的混合血清作为确认血清,将不同稀释度的确认血清与收集的HBsAb阳性混合血清中和,筛选并确定确认血清中HBsAg的最佳试验浓度.收集40例HBsAg和HBsAb双阳性的血清,与确认血清中和后采用ELISA检测COI的下降率,验证HBsAg和HBsAb双阳性标本中HBsAb阳性的真实性.结果 确认血清HBsAg浓度为2000 COI时对HBsAb的中和效果最好,ELISA确认法对40例HBsAg和HBsAb双阳性标本确认结果为37例真阳性和3例假阳性,与ECLIA法完全一致.结论 成功建立了HBsAg和HBsAb双阳性血清HBsAb的确认方法,该方法简单、准确且成本较低. Objective Establish a kind of confirmation method based on ELISA,and use to verify authenticity of HBsAb + in HBsAg + HBsAb + serum,pick and get rid of the false masculine gender the result,and avoid the mistake diagnosis.Method Collect 60 pieces of serum whose thick degree of H BsAg at 1000 COI above tested by ECLIA as confirm serum,mixed the confirm serum of different dilution with HBsAb positive serum to screen and verify best thick degree of HBsAg.Collected 40 pieces of HBsAg + HBsAb +serum,ELISA tested the descend rate of HBsAb COI after neutralized with confirm serum in order to confirm authenticity of HBsAb + in pieces of HBsAg + HBsAb + serum.Result When thick degree of HBsAg is 2000 COI,the performance of neutralization to HBsAb is best.The ELISA confirmatory test is fully consistent with the ECLIA method with true positive of 37 pieces of HBsAg + HBsAb + serum while falsepositive of 3 pieces of serum.Conclusion The ELISA confirm method is a simple,accurate and low cost initial validation method.
出处 《中华实验和临床病毒学杂志》 CAS CSCD 北大核心 2011年第6期492-494,共3页 Chinese Journal of Experimental and Clinical Virology
关键词 肝炎 乙型 肝炎表面抗原 乙型 肝炎抗体 乙型 Hepatitis B Hepatitis B surface antigems Hepatitis B antibodies
  • 相关文献

参考文献9

二级参考文献19

  • 1骆抗先.乙型肝炎-基础与临床[M].北京:人民卫生出版社,1997.453-464.
  • 2[2]Wang Y M, Ng W C, Lo S K, et al. Detection of pre-S/S gene mutants in chronic hepatitis B barriers with concurrent hepatitis B surface antibody and hepatitis B surface antigen[J]. J Gastroenterol, 1999, 34(5): 600-606.
  • 3[3]Kfoury-Baz E M, Zheng J, Mazuruk K, et al. Characterization of a novel hepatitis B virus mutant: demonstration of mutation-induced hepatitis B virus surface antigen group specific "a" determinant conformation change and its application in diagnostic assays[J]. Transfus Med, 2001, 11(5): 355-362.
  • 4[4]Lee K M, Kim Y S, Ko Y Y, et al. Emergence of vaccine-induced escape of hepatitis B virus with multiple surface gene mutations in a korean child. J Korean Med Sci, 2001, 16(3): 359-362.
  • 5[5]Heijtink R A, VanBergen P, Van Roos malen M H, et al. Anti-HBs after hepatitis B immunization with plasma-derived and recombinant DNA-derived vaccines: binding to mutant HBsAg. Vaccine, 2001, 19: 3671-3680.
  • 6[6]Fiordalisi G, Ghiotto F, Castelnuovo F, et al. Analysis of the hepatitis B virus genome and immune response in HBsAg, anti-HBs positive chronic hepatitis[J]. J Hepatol, 1994, 20(4): 487.
  • 7Bodner A J, Britz J A. Copalis technology. Immunoassay automation: an updated to system [M]. San diago: Academic Press, 1996. 253 - 257.
  • 8David H W. Rapid, automated assay for progesterone on the abbott AxSYM analyzer[J]. Clin Chem, 1998, 44(1): 86.
  • 9Patterson W, Werness P, Payne W. Random and continuousacess immunoassay with chemiluminescent detection by acess automated analyzer[J]. Clin Chem, 1994, 40: 20 - 24.
  • 10Christofides N D, Shehan C P. Enhanced chemiluminescence labeled- antibody immunoassay (Amerlite - MAB) for free thyroxine: design, development and technical variation[J]. Clin Chem, 1995, 41(1): 17 - 23.

共引文献141

同被引文献29

  • 1李金明.感染性疾病血清学检验中应重视对弱反应性标本的确认[J].中华检验医学杂志,2006,29(7):577-580. 被引量:126
  • 2Parizad EG, Khosravi A, Parizad EG, et al, Evaluation of chronic hepatitis B infection in patients with seronegative HBsAg [ J ]. Iranian Journal of Public Health ,2012,41 ( 2 ) : 100 - 104.
  • 3Kwon SY, Cho NS, Cho YJ, et al, Establishment of an HBsAg mixed titer performance panel and HBsAg working standard for quality con- trol of HBsAg diagnostic kits in Korea[ J]. Journal of Clinical Virolo- gy,2010,48 (2) :109 - 114.
  • 4Chen D, Kaplan LA. Performance of a new generation chemilumines- cent assay for hepatitis B surface antigen [ J ]. Clinical Chemistry, 2006,52(8) :1592 - 1598.
  • 5Chu FY,Su FH, Cheng SH, et al, Hepatitis B surface antigen con- firmatory testing for diagnosis of hepatitis B virus infection in Taiwan [Jl. Journal of Medical Virology, 2011,83(9):1514-1521.
  • 6Fletcher GJ, Gnanamony M, David J, et al. Do we need an 'in - house' neutralization assay for confirmation of hepatitis B surface anti- gen? Answers from a tertiary care hospital in India [ J ]. Journal of Gas- troenterology and Hepatology,2010,25 ( 5 ) : 942 - 945.
  • 7Tajiri K, Ozawa T, Jin A, et al. Analysis of the epitope and neutrali- zing capacity of human monoclonal antibodies induced by hepatitis B vaccine[ J]. Antiviral Research, 2010,87( 1 ) :40 -49.
  • 8Su TH, Hsu CS, Chen CL, et al. Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B[J]. Antivir Ther, 2010,15 (8):1133-1 139.
  • 9Moerman B, Moons V, Sommer H, et al. Evaluation of sensitivity for wild type and mutant forms of hepatitis B surface antigen by four commercial HBsAg assaysFJ]. Clin Lab, 2004,50 ( 3/4) : 116- 159.
  • 10Jia JD, Hong M, Wei L, et al. Multicentre evaluation of the Elec- sys(A (R)) hepatitis B surface antigen II assay for detection of HBsAg in comparison with other commercially available assays [J]. Med Microbiol Immunol,2009,198(4) :263-269.

引证文献6

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部